Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In August 2025, Wegovy received accelerated approval for the treatment of adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver
Whats your morning routine
They are characterized by an increased number of melanocytes at the dermal-epidermal junction
Other potential side effects can include: Diarrhea Constipation Abdominal (stomach) pain Headache Fatigue Dyspepsia (indigestion) Dizziness Abdominal distension Eructation or belching Hypoglycemia (low blood sugar) in patients with type 2 diabetes Flatulence Gastroenteritis (an intestinal infection) Gastroesophageal reflux disease (a type of digestive disorder)
Increasing the dosage quickly or starting retatrutide at high doses can result in serious side effects
US$ 24.47
US$ 25.42
US$ 29.09
US$ 23.71
US$ 25.66
